Propel testing excellence with Mayo Clinic quality
Mayo Clinic Laboratories is a one-stop laboratory solution, offering commercial laboratories a vast testing menu, unparalleled customer service, and optimized processes. We work collaboratively with partners to assess their needs, providing the testing they need to expand into new areas and meet their business goals.
As the reference lab for Mayo Clinic, we’ve developed robust logistics and testing protocols applied uniformly for all specimens received, no matter their geographic origin. Whether you send us one test order or thousands, each sample receives the same treatment and level of care, ensuring superior results that help our partners better serve their clients.
“Our clients want personal experiences. They want someone to answer the phone. They want someone to provide answers when they're looking for results of a sample sent a couple days ago. and we deliver those answers.”
Angie Reese-Davis, director of operations, logistics, and specimen services, Mayo Clinic Laboratories
Our difference
News and updates
The latest
In this episode of the “Leveraging the Laboratory” podcast, Jane Hermansen, outreach manager at Mayo Clinic Laboratories, welcomes Chelsea Conn, Mayo Clinic Laboratories’ director of regulatory affairs. Together, they break down the latest regulatory changes and share actionable strategies to help outreach programs stay informed and prepared.
In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides answers.
This Feature Includes: Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure.
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate a malfunctioning metal hip implant. A Mayo Clinic study found that synovial fluid testing for those elements is more sensitive than serum or whole blood testing.
Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.
Mayo Clinic researchers have identified clear differences in brain and spinal cord scarring in patients with demyelinating diseases.
Today's Highlights Include: 5 reasons to consider becoming an organ donor, why so many women in middle age are on antidepressants, and should you get a second COVID-19 vaccine booster?
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt discuss how innovation in laboratories can address unmet patient needs and expand access to health care.
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Saliva testing has emerged as a viable option for obtaining rapid, reliable test results during the COVID-19 pandemic. Mayo Clinic’s Dr. Darci Block considers how this type of testing may expand beyond the pandemic, and the obstacles in its way.
Before he arrived at Mayo Clinic, Tim Brantner worked for a variety of organizations outside of health care. He joined Mayo Clinic Laboratories 14 years ago to help tell the labs’ story.
The Specimens Operations team at Mayo Clinic Laboratories is dedicated to ensuring that patient samples reach the labs quickly and safely. Get an inside look at how they accomplish that crucial goal for more than 40,000 specimens every day.
Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which have associations to thiopurine metabolization.